Bharat Immunological Corp Reports Decline in Q3 Financials
Bharat Immunological & Biological Corporation, a microcap pharmaceutical company, recently announced its financial results for the quarter ended September 2023. The company reported a decline in net sales and standalone net profit, with a growth of -7.19% and -18.30% respectively, compared to the previous quarter.According to MarketsMOJO, a leading financial analysis platform, the stock call for Bharat Immunological & Biological Corporation is 'Sell'. The company's operating profit (PBDIT) excluding other income also saw a decline of -8.56% in the quarter ended September 2023, compared to -7.46% in the previous quarter. However, there was a growth of 21.51% in interest expenses in the same period.
The company's operating profit margin (excluding other income) has not been reported in the last few periods. This quarter, Bharat Immunological & Biological Corporation has seen a negative financial performance, with a score of -9 compared to -14 in the last three months.
The financial analysis of the company's September 2023 quarter highlights some concerning trends. Net sales for the nine-month period have declined by -87.03% year on year, indicating a negative sales trend in the near term. Similarly, the profit after tax (PAT) for the same period has also declined by -87.03%, showing a negative trend in the company's profitability.
Moreover, the company's profit before tax (PBT) excluding other income for the quarter was the lowest in the last five quarters at Rs -6.81 crore. This indicates a negative trend in the company's near-term PBT. The earnings per share (EPS) for the quarter was also the lowest in the last five quarters at Rs -1.14, showing a decline in profitability and lower earnings for shareholders.
In conclusion, Bharat Immunological & Biological Corporation's financial performance for the quarter ended September 2023 has been negative, with declining sales and profitability. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
